The Drug Development Process - From Discovery to Commercialization 2014
conferences > Education, Training conferences > The Drug Development Process - From Discovery to Commercialization
May 5 - 7, 2014
Los Angeles CA , USA
The drug development process involves a series of lengthy steps that determine the degree of success for every drug brought to the market. Decisions made throughout the process affect every aspect of future development and impact heavily on commercialization strategies.
Included in the course content is an overview of the regulatory and pre-marketing steps that occur to ensure a successful launch. The course also covers sales planning and the commercialization decisions that affect the development of the drug.
Topics include:
Basic concepts of drug discovery and testing
Scientific, regulatory, and management framework for modern pharmaceutical development
Pre-clinical study requirements and how information gathered is used for human clinical studies
The four major clinical phases (1-4) in the drug development process and the rationale for each and an introduction to the special problems of each phase
The economics of drug development
Cost/benefit issues in clinical development
Discovery and development milestones
The IND Process
The NDA Process
FDA Interactions – Application review and approval process
Patents and exclusivity
The rationale of government regulations and how they effect the development process
The relationship between the Code of Federal Regulations and ICH GCP
Designing optimal clinical trials
Drug labeling, marketing, and pharmacoeconomic studies
Project management cross functional teams during the development process
Included in the course content is an overview of the regulatory and pre-marketing steps that occur to ensure a successful launch. The course also covers sales planning and the commercialization decisions that affect the development of the drug.
Topics include:
Basic concepts of drug discovery and testing
Scientific, regulatory, and management framework for modern pharmaceutical development
Pre-clinical study requirements and how information gathered is used for human clinical studies
The four major clinical phases (1-4) in the drug development process and the rationale for each and an introduction to the special problems of each phase
The economics of drug development
Cost/benefit issues in clinical development
Discovery and development milestones
The IND Process
The NDA Process
FDA Interactions – Application review and approval process
Patents and exclusivity
The rationale of government regulations and how they effect the development process
The relationship between the Code of Federal Regulations and ICH GCP
Designing optimal clinical trials
Drug labeling, marketing, and pharmacoeconomic studies
Project management cross functional teams during the development process
Related events
The Drug Development Process - From Discovery to Commercialization November 6 - 8, 2015
The Drug Development Process - From Discovery to Commercialization October 23 - 25, 2015
The Drug Development Process - From Discovery to Commercialization November 6 - 8, 2014
The Drug Development Process - From Discovery to Commercialization October 23 - 25, 2014
The Drug Development Process - From Discovery to Commercialization March 12 - 14, 2014
The Drug Development Process - From Discovery to Commercialization November 6 - 8, 2013
The Drug Development Process - From Discovery to Commercialization October 23 - 25, 2013
The Drug Development Process - From Discovery to Commercialization November 7 - 9, 2012
The Drug Development Process - From Discovery to Commercialization September 19 - 21, 2012
The Drug Development Process - From Discovery to Commercialization August 15 - 17, 2012
The Drug Development Process - From Discovery to Commercialization November 9 - 11, 2011
The Drug Development Process - From Discovery to Commercialization September 28 - 30, 2011
The Drug Development Process - From Discovery to Commercialization March 2 - 4, 2011
